RedHill Biopharma : Exercise of Existing Warrants Resulting

UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


Washington, D.C....

Related Keywords

, Exchange Commission , Nasdaq , Company Expanded Access Program , Product Development Pipeline , Company Annual Report On Form , Private Securities Litigation Reform Act , Nasdaq Capital Market , Development Pipeline , Expanded Access Program , Annual Report , Markets ,